aspartic acid has been researched along with Osteosarcoma in 4 studies
Aspartic Acid: One of the non-essential amino acids commonly occurring in the L-form. It is found in animals and plants, especially in sugar cane and sugar beets. It may be a neurotransmitter.
aspartic acid : An alpha-amino acid that consists of succinic acid bearing a single alpha-amino substituent
L-aspartic acid : The L-enantiomer of aspartic acid.
Osteosarcoma: A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Osteosarcoma is a malignancy of the bone that primarily affects adolescents." | 1.40 | Bone-targeted acid-sensitive doxorubicin conjugate micelles as potential osteosarcoma therapeutics. ( Kopeček, J; Low, SA; Yang, J, 2014) |
| "Another solid tumor, Ridgway osteogenic sarcoma, which is sensitivie to many established chemotherapeutic agents, did not respond to PALA." | 1.26 | Antitumor activity of N-(phosphonacetyl)-L-aspartic acid, a transition-state inhibitor of aspartate transcarbamylase. ( Goldin, A; Inouye, T; Johnson, RK; Stark, GR, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Low, SA | 1 |
| Yang, J | 1 |
| Kopeček, J | 1 |
| El-Hizawi, S | 1 |
| Lagowski, JP | 1 |
| Kulesz-Martin, M | 1 |
| Albor, A | 1 |
| Johnson, RK | 1 |
| Inouye, T | 1 |
| Goldin, A | 1 |
| Stark, GR | 1 |
| Ohnuma, T | 1 |
| Holland, JF | 1 |
| Freeman, A | 1 |
| Sinks, LF | 1 |
4 other studies available for aspartic acid and Osteosarcoma
| Article | Year |
|---|---|
Bone-targeted acid-sensitive doxorubicin conjugate micelles as potential osteosarcoma therapeutics.
Topics: Amino Acids; Aspartic Acid; Bone and Bones; Bone Neoplasms; Cell Line, Tumor; Doxorubicin; Drug Carr | 2014 |
Induction of gene amplification as a gain-of-function phenotype of mutant p53 proteins.
Topics: Aspartic Acid; Bone Neoplasms; Camptothecin; DNA Topoisomerases, Type I; Enzyme Inhibitors; Gene Amp | 2002 |
Antitumor activity of N-(phosphonacetyl)-L-aspartic acid, a transition-state inhibitor of aspartate transcarbamylase.
Topics: Animals; Antineoplastic Agents; Aspartate Carbamoyltransferase; Aspartic Acid; Carbamyl Phosphate; D | 1976 |
Biochemical and pharmacological studies with asparaginase in man.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Asparaginase; Asparagine; Aspartic Acid; Child; Colo | 1970 |